John Paulson (BHC) receives $250K RSU award and reports large fund holdings
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Paulson John reported acquisition or exercise transactions in this Form 4 filing.
Bausch Health Companies Inc. director John Paulson reported an equity compensation grant rather than an open-market trade. He received an award of 45,871 restricted share units with a grant date value of $250,000, which vest on the date immediately preceding the company’s next annual meeting and will be settled in common shares.
Following this award, Paulson directly holds 417,565 common shares. Investment funds managed by Paulson Capital Inc. directly hold 73,255,869 common shares; Paulson may be deemed an indirect beneficial owner of those fund holdings but disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Paulson John
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares, No Par Value | 45,871 | $0.00 | -- |
| holding | Common Shares, No Par Value | -- | -- | -- |
Holdings After Transaction:
Common Shares, No Par Value — 417,565 shares (Direct);
Common Shares, No Par Value — 73,255,869 shares (Indirect, By Managed Funds)
Footnotes (1)
- Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.
Key Figures
RSU shares granted: 45,871 shares
Grant date value: $250,000
Grant price per share: $0.0000 per share
+3 more
6 metrics
RSU shares granted
45,871 shares
Restricted share units granted to non-employee director John Paulson
Grant date value
$250,000
Value of RSU award to non-employee directors
Grant price per share
$0.0000 per share
Reported transaction price for RSU acquisition
Direct shares after grant
417,565 shares
John Paulson’s direct Bausch Health holdings after RSU award
Indirect fund holdings
73,255,869 shares
Shares directly owned by funds managed by Paulson Capital Inc.
RSU vesting trigger
Before next annual meeting
RSUs vest on date immediately preceding next annual shareholder meeting
Key Terms
restricted share units ("RSUs"), grant date value, beneficial owner, pecuniary interest, +1 more
5 terms
grant date value financial
"The RSUs have a grant date value of $250,000, vest on the date immediately preceding"
beneficial owner financial
"may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
pecuniary interest financial
"disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein"
investment manager financial
"Paulson is the investment manager of investment funds (the "Funds")"
FAQ
What insider transaction did John Paulson report for BHC on this Form 4?
John Paulson reported an award of 45,871 restricted share units in Bausch Health Companies Inc. as compensation for serving as a non-employee director, not an open-market purchase or sale, with the units settling in common shares after vesting.
What is the value of John Paulson’s RSU grant in Bausch Health (BHC)?
The restricted share unit grant to John Paulson has a grant date value of $250,000. These RSUs were awarded to him as a non-employee director and will be settled in Bausch Health common shares once they vest before the next annual shareholder meeting.
When do John Paulson’s Bausch Health RSUs vest and how are they settled?
John Paulson’s restricted share units vest on the date immediately preceding Bausch Health’s next annual meeting of shareholders. Once vested, the RSUs are settled in common shares of Bausch Health Companies Inc., increasing his direct share ownership accordingly.
What Bausch Health stake is held through funds managed by Paulson Capital Inc.?
Investment funds managed by Paulson Capital Inc. directly own 73,255,869 Bausch Health common shares. John Paulson, as the controlling person of Paulson Capital Inc., may be deemed an indirect beneficial owner but disclaims beneficial ownership beyond his pecuniary interest.
Is John Paulson’s Bausch Health Form 4 transaction a buy or a sale?
The reported Form 4 transaction is an acquisition via a restricted share unit grant, not a market buy or sale. It represents equity compensation for John Paulson’s role as a non-employee director of Bausch Health Companies Inc., awarded at no cash cost per share.